Diverse studies show that VPA enhanced H3 acetylation and consequently reduced α-synuclein-mediated toxicity and decreased pro-inflammatory mediators, in PD cell models and animals exposed to PD-promoting toxic agents, such as MPTP, rotenone, or lipopolysaccaride [162,163,164,165]. This evidence concerns the gene SNCA and Parkinson disease.